Alpha-2A adrenergic receptor (ADRA2A) modulates susceptibility to Raynaud's disease

被引：0
|
作者：
Tervi, Anniina [1 ]
Rasanen, Markus [2 ]
Lammi, Vilma [1 ]
Abner, Erik [3 ]
Esko, Tonu [3 ]
Lane, Jacqueline [4 ,5 ,6 ,7 ]
Maher, Matthew [6 ]
Heckman, Caroline A. [1 ]
Quertermous, Thomas [2 ]
Jones, Samuel [1 ]
Ollila, Hanna [1 ,5 ,6 ,7 ,8 ]
机构：
[1] Univ Helsinki, Inst Mol Med Finland, FIMM, HiLIFE, Helsinki, Finland
[2] Stanford Univ, Sch Med, Div Cardiovasc Med, Stanford, CA USA
[3] Univ Tartu, Inst Genom, Tartu, Estonia
[4] Brigham & Womens Hosp, Div Sleep & Circadian Disorders, Boston, MA USA
[5] Harvard Med Sch, Boston, MA 02115 USA
[6] Broad Inst MIT & Harvard, Cambridge, MA USA
[7] Massachusetts Gen Hosp, Ctr Genom Med, Boston, MA 02114 USA
[8] Massachusetts Gen Hosp, Anesthesia Crit Care & Pain Med, Boston, MA 02114 USA
来源：
EUROPEAN JOURNAL OF HUMAN GENETICS | 2024年 / 32卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
P25.051.C
引用
收藏
页码：786 / 786
页数：1
相关论文
共 50 条
  • [1] Alpha-2A adrenergic receptor gene (ADRA2A) polymorphism in a Turkish population
    Emerce-Tufan, Esra
    Karahalil, Bensu
    Coskun, E-Rdern
    TOXICOLOGY LETTERS, 2008, 180 : S81 - S81
  • [2] Possible association of the alpha-2A adrenergic receptor gene (ADRA2A) with symptoms of attention-deficit/hyperactivity disorder
    Wang, B
    Wang, YF
    Zhou, RL
    Li, J
    Qian, QJ
    Yang, L
    Guan, LL
    Faraone, SV
    AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS, 2006, 141B (02) : 130 - 134
  • [3] The effect of alpha-2A adrenergic receptor (ADRA2A) genetic polymorphisms on the depth of sedation of dexmedetomidine: a genetic observational pilot study
    Choi, Yoon Ji
    Park, Kyu Hee
    Park, Ju Yeon
    Min, Won Kee
    Lee, Yoon Sook
    BRAZILIAN JOURNAL OF ANESTHESIOLOGY, 2022, 72 (02): : 241 - 246
  • [4] ADRA2A and IRX1 are putative risk genes for Raynaud's phenomenon
    Hartmann, Sylvia
    Yasmeen, Summaira
    Jacobs, Benjamin M.
    Denaxas, Spiros
    Pirmohamed, Munir
    Gamazon, Eric R.
    Caulfield, Mark J.
    Hemingway, Harry
    Pietzner, Maik
    Langenberg, Claudia
    NATURE COMMUNICATIONS, 2023, 14 (01)
  • [5] Analysis of the alpha adrenergic receptor gene 2A (ADRA2A) in patients with Tourette's syndrome and attention-deficit/hyperactivity disorder
    Khan, SA
    Yoon, D
    Yao, Y
    Singer, HS
    AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS, 2005, 138B (01) : 57 - 57
  • [6] ADRA2A and IRX1 are putative risk genes for Raynaud’s phenomenon
    Sylvia Hartmann
    Summaira Yasmeen
    Benjamin M. Jacobs
    Spiros Denaxas
    Munir Pirmohamed
    Eric R. Gamazon
    Mark J. Caulfield
    Harry Hemingway
    Maik Pietzner
    Claudia Langenberg
    Nature Communications, 14
  • [7] Association of alpha 2A adrenergic receptor gene (ADRA2A) polymorphism with irritable bowel syndrome, microscopic and ulcerative colitis
    Sikander, Arbab
    Rana, Satya Vati
    Sharma, Sanjeev K.
    Sinha, Saroj Kant
    Arora, Sunil K.
    Prasad, Kaushal Kishor
    Singh, Kartar
    CLINICA CHIMICA ACTA, 2010, 411 (1-2) : 59 - 63
  • [8] Preliminary Findings of the Distribution of Alpha-2-Adrenergic Receptor (ADRA2A) rs1800544 Polymorphisms in Kickboxing Players
    Eken, Basak Funda
    Savci, Ayse Aysun
    Polat, Tolga
    Yilmaz, Ozlem Ozge
    Silar, Cisem
    Aslan, Beste Tacal
    Oktay, Sehkar
    Ulucan, Korkut
    CLINICAL AND EXPERIMENTAL HEALTH SCIENCES, 2021, 11 (04): : 742 - 745
  • [9] Possible association of the alpha-2A-adrenergic receptor gene (ADRA2A) with symptoms of attention-deficit/hyperactivity disorder
    Wang, B
    Wang, Y
    Zhou, R
    Li, J
    Qian, Q
    Yang
    Guan
    Faraone, SV
    AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS, 2005, 138B (01) : 63 - 63
  • [10] Is the α-2A adrenergic receptor gene (ADRA2A) associated with attention-deficit/hyperactivity disorder?
    Roman, T
    Schmitz, M
    Polanczyk, GV
    Eizirik, M
    Rohde, LA
    Hutz, MH
    AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS, 2003, 120B (01) : 116 - 120
12345